Global Peanut Allergy Therapeutics Market Research Report 2025

Peanut Allergy Therapeutics Market

Peanut Allergy Therapeutics refer to a range of preventive and treatment approaches designed to address the immune system’s abnormal response triggered by peanut proteins. These therapies include oral immunotherapy (OIT), subcutaneous immunotherapy, and emerging biologics and small molecule drugs, aiming to increase patients’ tolerance to peanuts and reduce the frequency and severity of allergic reactions. As one of the most common and potentially life-threatening food allergies globally affecting both children and adults, peanut allergy significantly impacts patient quality of life and imposes economic burdens on society. With advancements in precision medicine and immune modulation technologies, peanut allergy treatment is evolving from mere avoidance strategies to active immune regulation, driving rapid growth in clinical practice and market demand.

In recent years, rising global awareness of food safety and the expanding population of peanut allergy patients have created significant growth opportunities for the peanut allergy therapeutics market. Governments and regulatory bodies worldwide have progressively improved support policies, facilitating clinical approval and market introduction of immunotherapies and innovative biologics. Advances in medical technologies have enhanced the maturity of oral immunotherapy and personalized treatment regimens, markedly improving patient compliance and safety, thereby accelerating market demand. Multiple biopharmaceutical companies have increased R&D investments, actively developing differentiated products and combination therapies, contributing to a diversified and high-value competitive landscape.Despite vast market potential, the peanut allergy therapeutics sector faces several challenges. Allergic reactions and safety concerns during treatment limit patient acceptance and slow adoption rates. Uneven distribution of medical resources across regions affects treatment accessibility and coverage. Additionally, the high costs and complex management of therapies pose challenges for reimbursement systems and patient affordability. The lack of standardized treatment protocols and regulatory discrepancies further complicate cross-border product launches. Companies must carefully balance innovation breakthroughs with risk management to ensure stable market growth.Downstream demand for peanut allergy therapeutics is moving toward precision and comprehensive care management. With broader adoption of early screening technologies and increased public awareness, more potential patients will receive timely diagnosis and intervention, fostering wider use of immunotherapies. Collaboration among primary care physicians, allergy specialists, and school health programs will strengthen, promoting personalized and long-term treatment management. There is growing demand for safer, more convenient products, while digital health solutions and telemedicine support will become vital tools to enhance adherence and monitor treatment efficacy. Overall, the market is evolving into an integrated ecosystem encompassing diagnosis, therapy, and follow-up care.

This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.

The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Market Segmentation

Scope of Peanut Allergy Therapeutics Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peanut Allergy Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Epinephrine Injection

1.2.3 Antihistamines

1.2.4 Oral Immunotherapy

1.2.5 Other

1.3 Market by Distribution Channel

1.3.1 Global Peanut Allergy Therapeutics Market Growth by Distribution Channel: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Peanut Allergy Therapeutics Market Perspective (2020-2031)

2.2 Global Peanut Allergy Therapeutics Growth Trends by Region

2.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peanut Allergy Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Peanut Allergy Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Peanut Allergy Therapeutics Market Dynamics

2.3.1 Peanut Allergy Therapeutics Industry Trends

2.3.2 Peanut Allergy Therapeutics Market Drivers

2.3.3 Peanut Allergy Therapeutics Market Challenges

2.3.4 Peanut Allergy Therapeutics Market Restraints

3.1 Global Top Peanut Allergy Therapeutics Players by Revenue

3.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Top Peanut Allergy Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peanut Allergy Therapeutics Revenue

3.4 Global Peanut Allergy Therapeutics Market Concentration Ratio

3.4.1 Global Peanut Allergy Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peanut Allergy Therapeutics Revenue in 2024

3.5 Global Key Players of Peanut Allergy Therapeutics Head office and Area Served

3.6 Global Key Players of Peanut Allergy Therapeutics, Product and Application

3.7 Global Key Players of Peanut Allergy Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031)

5.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2020-2025)

5.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031)

6.1 North America Peanut Allergy Therapeutics Market Size (2020-2031)

6.2 North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peanut Allergy Therapeutics Market Size by Country (2020-2025)

6.4 North America Peanut Allergy Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7.1 Europe Peanut Allergy Therapeutics Market Size (2020-2031)

7.2 Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peanut Allergy Therapeutics Market Size by Country (2020-2025)

7.4 Europe Peanut Allergy Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific Peanut Allergy Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America Peanut Allergy Therapeutics Market Size (2020-2031)

9.2 Latin America Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peanut Allergy Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Peanut Allergy Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Peanut Allergy Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Viatris

11.1.1 Viatris Company Details

11.1.2 Viatris Business Overview

11.1.3 Viatris Peanut Allergy Therapeutics Introduction

11.1.4 Viatris Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.1.5 Viatris Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Peanut Allergy Therapeutics Introduction

11.2.4 Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.2.5 Bayer Recent Development

11.3 UCB Pharma

11.3.1 UCB Pharma Company Details

11.3.2 UCB Pharma Business Overview

11.3.3 UCB Pharma Peanut Allergy Therapeutics Introduction

11.3.4 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.3.5 UCB Pharma Recent Development

11.4 J & J

11.4.1 J & J Company Details

11.4.2 J & J Business Overview

11.4.3 J & J Peanut Allergy Therapeutics Introduction

11.4.4 J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.4.5 J & J Recent Development

11.5 Perrigo

11.5.1 Perrigo Company Details

11.5.2 Perrigo Business Overview

11.5.3 Perrigo Peanut Allergy Therapeutics Introduction

11.5.4 Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.5.5 Perrigo Recent Development

11.6 GSK

11.6.1 GSK Company Details

11.6.2 GSK Business Overview

11.6.3 GSK Peanut Allergy Therapeutics Introduction

11.6.4 GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.6.5 GSK Recent Development

11.7 Kaleo

11.7.1 Kaleo Company Details

11.7.2 Kaleo Business Overview

11.7.3 Kaleo Peanut Allergy Therapeutics Introduction

11.7.4 Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.7.5 Kaleo Recent Development

11.8 Amneal Pharma

11.8.1 Amneal Pharma Company Details

11.8.2 Amneal Pharma Business Overview

11.8.3 Amneal Pharma Peanut Allergy Therapeutics Introduction

11.8.4 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.8.5 Amneal Pharma Recent Development

11.9 ALK Abello

11.9.1 ALK Abello Company Details

11.9.2 ALK Abello Business Overview

11.9.3 ALK Abello Peanut Allergy Therapeutics Introduction

11.9.4 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.9.5 ALK Abello Recent Development

11.10 Aimmune Therapeutics

11.10.1 Aimmune Therapeutics Company Details

11.10.2 Aimmune Therapeutics Business Overview

11.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Introduction

11.10.4 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.10.5 Aimmune Therapeutics Recent Development

11.11 HUAPONT Pharm

11.11.1 HUAPONT Pharm Company Details

11.11.2 HUAPONT Pharm Business Overview

11.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Introduction

11.11.4 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.11.5 HUAPONT Pharm Recent Development

11.12 Allergy Therapeutics

11.12.1 Allergy Therapeutics Company Details

11.12.2 Allergy Therapeutics Business Overview

11.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Introduction

11.12.4 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.12.5 Allergy Therapeutics Recent Development

11.13 ASIT Biotech

11.13.1 ASIT Biotech Company Details

11.13.2 ASIT Biotech Business Overview

11.13.3 ASIT Biotech Peanut Allergy Therapeutics Introduction

11.13.4 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.13.5 ASIT Biotech Recent Development

11.14 Sanofi

11.14.1 Sanofi Company Details

11.14.2 Sanofi Business Overview

11.14.3 Sanofi Peanut Allergy Therapeutics Introduction

11.14.4 Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.14.5 Sanofi Recent Development

11.15 DBV Technologies

11.15.1 DBV Technologies Company Details

11.15.2 DBV Technologies Business Overview

11.15.3 DBV Technologies Peanut Allergy Therapeutics Introduction

11.15.4 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.15.5 DBV Technologies Recent Development

11.16 HAL Allergy

11.16.1 HAL Allergy Company Details

11.16.2 HAL Allergy Business Overview

11.16.3 HAL Allergy Peanut Allergy Therapeutics Introduction

11.16.4 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.16.5 HAL Allergy Recent Development

11.17 Intrommune Therapeutics

11.17.1 Intrommune Therapeutics Company Details

11.17.2 Intrommune Therapeutics Business Overview

11.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Introduction

11.17.4 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025)

11.17.5 Intrommune Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Key Players of Epinephrine Injection

 Table 3. Key Players of Antihistamines

 Table 4. Key Players of Oral Immunotherapy

 Table 5. Key Players of Other

 Table 6. Global Peanut Allergy Therapeutics Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031

 Table 7. Global Peanut Allergy Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 8. Global Peanut Allergy Therapeutics Market Size by Region (2020-2025) & (US$ Million)

 Table 9. Global Peanut Allergy Therapeutics Market Share by Region (2020-2025)

 Table 10. Global Peanut Allergy Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

 Table 11. Global Peanut Allergy Therapeutics Market Share by Region (2026-2031)

 Table 12. Peanut Allergy Therapeutics Market Trends

 Table 13. Peanut Allergy Therapeutics Market Drivers

 Table 14. Peanut Allergy Therapeutics Market Challenges

 Table 15. Peanut Allergy Therapeutics Market Restraints

 Table 16. Global Peanut Allergy Therapeutics Revenue by Players (2020-2025) & (US$ Million)

 Table 17. Global Peanut Allergy Therapeutics Market Share by Players (2020-2025)

 Table 18. Global Top Peanut Allergy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peanut Allergy Therapeutics as of 2024)

 Table 19. Ranking of Global Top Peanut Allergy Therapeutics Companies by Revenue (US$ Million) in 2024

 Table 20. Global 5 Largest Players Market Share by Peanut Allergy Therapeutics Revenue (CR5 and HHI) & (2020-2025)

 Table 21. Global Key Players of Peanut Allergy Therapeutics, Headquarters and Area Served

 Table 22. Global Key Players of Peanut Allergy Therapeutics, Product and Application

 Table 23. Global Key Players of Peanut Allergy Therapeutics, Date of Enter into This Industry

 Table 24. Mergers & Acquisitions, Expansion Plans

 Table 25. Global Peanut Allergy Therapeutics Market Size by Type (2020-2025) & (US$ Million)

 Table 26. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2020-2025)

 Table 27. Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

 Table 28. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2026-2031)

 Table 29. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2025) & (US$ Million)

 Table 30. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2020-2025)

 Table 31. Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2026-2031) & (US$ Million)

 Table 32. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2026-2031)

 Table 33. North America Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 34. North America Peanut Allergy Therapeutics Market Size by Country (2020-2025) & (US$ Million)

 Table 35. North America Peanut Allergy Therapeutics Market Size by Country (2026-2031) & (US$ Million)

 Table 36. Europe Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 37. Europe Peanut Allergy Therapeutics Market Size by Country (2020-2025) & (US$ Million)

 Table 38. Europe Peanut Allergy Therapeutics Market Size by Country (2026-2031) & (US$ Million)

 Table 39. Asia-Pacific Peanut Allergy Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 40. Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2020-2025) & (US$ Million)

 Table 41. Asia-Pacific Peanut Allergy Therapeutics Market Size by Region (2026-2031) & (US$ Million)

 Table 42. Latin America Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 43. Latin America Peanut Allergy Therapeutics Market Size by Country (2020-2025) & (US$ Million)

 Table 44. Latin America Peanut Allergy Therapeutics Market Size by Country (2026-2031) & (US$ Million)

 Table 45. Middle East & Africa Peanut Allergy Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 46. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2020-2025) & (US$ Million)

 Table 47. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2026-2031) & (US$ Million)

 Table 48. Viatris Company Details

 Table 49. Viatris Business Overview

 Table 50. Viatris Peanut Allergy Therapeutics Product

 Table 51. Viatris Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 52. Viatris Recent Development

 Table 53. Bayer Company Details

 Table 54. Bayer Business Overview

 Table 55. Bayer Peanut Allergy Therapeutics Product

 Table 56. Bayer Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 57. Bayer Recent Development

 Table 58. UCB Pharma Company Details

 Table 59. UCB Pharma Business Overview

 Table 60. UCB Pharma Peanut Allergy Therapeutics Product

 Table 61. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 62. UCB Pharma Recent Development

 Table 63. J & J Company Details

 Table 64. J & J Business Overview

 Table 65. J & J Peanut Allergy Therapeutics Product

 Table 66. J & J Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 67. J & J Recent Development

 Table 68. Perrigo Company Details

 Table 69. Perrigo Business Overview

 Table 70. Perrigo Peanut Allergy Therapeutics Product

 Table 71. Perrigo Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 72. Perrigo Recent Development

 Table 73. GSK Company Details

 Table 74. GSK Business Overview

 Table 75. GSK Peanut Allergy Therapeutics Product

 Table 76. GSK Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 77. GSK Recent Development

 Table 78. Kaleo Company Details

 Table 79. Kaleo Business Overview

 Table 80. Kaleo Peanut Allergy Therapeutics Product

 Table 81. Kaleo Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 82. Kaleo Recent Development

 Table 83. Amneal Pharma Company Details

 Table 84. Amneal Pharma Business Overview

 Table 85. Amneal Pharma Peanut Allergy Therapeutics Product

 Table 86. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 87. Amneal Pharma Recent Development

 Table 88. ALK Abello Company Details

 Table 89. ALK Abello Business Overview

 Table 90. ALK Abello Peanut Allergy Therapeutics Product

 Table 91. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 92. ALK Abello Recent Development

 Table 93. Aimmune Therapeutics Company Details

 Table 94. Aimmune Therapeutics Business Overview

 Table 95. Aimmune Therapeutics Peanut Allergy Therapeutics Product

 Table 96. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 97. Aimmune Therapeutics Recent Development

 Table 98. HUAPONT Pharm Company Details

 Table 99. HUAPONT Pharm Business Overview

 Table 100. HUAPONT Pharm Peanut Allergy Therapeutics Product

 Table 101. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 102. HUAPONT Pharm Recent Development

 Table 103. Allergy Therapeutics Company Details

 Table 104. Allergy Therapeutics Business Overview

 Table 105. Allergy Therapeutics Peanut Allergy Therapeutics Product

 Table 106. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 107. Allergy Therapeutics Recent Development

 Table 108. ASIT Biotech Company Details

 Table 109. ASIT Biotech Business Overview

 Table 110. ASIT Biotech Peanut Allergy Therapeutics Product

 Table 111. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 112. ASIT Biotech Recent Development

 Table 113. Sanofi Company Details

 Table 114. Sanofi Business Overview

 Table 115. Sanofi Peanut Allergy Therapeutics Product

 Table 116. Sanofi Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 117. Sanofi Recent Development

 Table 118. DBV Technologies Company Details

 Table 119. DBV Technologies Business Overview

 Table 120. DBV Technologies Peanut Allergy Therapeutics Product

 Table 121. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 122. DBV Technologies Recent Development

 Table 123. HAL Allergy Company Details

 Table 124. HAL Allergy Business Overview

 Table 125. HAL Allergy Peanut Allergy Therapeutics Product

 Table 126. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 127. HAL Allergy Recent Development

 Table 128. Intrommune Therapeutics Company Details

 Table 129. Intrommune Therapeutics Business Overview

 Table 130. Intrommune Therapeutics Peanut Allergy Therapeutics Product

 Table 131. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2020-2025) & (US$ Million)

 Table 132. Intrommune Therapeutics Recent Development

 Table 133. Research Programs/Design for This Report

 Table 134. Key Data Information from Secondary Sources

 Table 135. Key Data Information from Primary Sources

 Table 136. Authors List of This Report

List of Figures

 Figure 1. Peanut Allergy Therapeutics Picture

 Figure 2. Global Peanut Allergy Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Peanut Allergy Therapeutics Market Share by Type: 2024 VS 2031

 Figure 4. Epinephrine Injection Features

 Figure 5. Antihistamines Features

 Figure 6. Oral Immunotherapy Features

 Figure 7. Other Features

 Figure 8. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2020-2031) & (US$ Million)

 Figure 9. Global Peanut Allergy Therapeutics Market Share by Distribution Channel: 2024 VS 2031

 Figure 10. Hospital Pharmacy Case Studies

 Figure 11. Retail Pharmacy Case Studies

 Figure 12. Other Case Studies

 Figure 13. Peanut Allergy Therapeutics Report Years Considered

 Figure 14. Global Peanut Allergy Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

 Figure 15. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

 Figure 16. Global Peanut Allergy Therapeutics Market Share by Region: 2024 VS 2031

 Figure 17. Global Peanut Allergy Therapeutics Market Share by Players in 2024

 Figure 18. Global Peanut Allergy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 19. The Top 10 and 5 Players Market Share by Peanut Allergy Therapeutics Revenue in 2024

 Figure 20. North America Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 21. North America Peanut Allergy Therapeutics Market Share by Country (2020-2031)

 Figure 22. United States Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 23. Canada Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 24. Europe Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 25. Europe Peanut Allergy Therapeutics Market Share by Country (2020-2031)

 Figure 26. Germany Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 27. France Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 28. U.K. Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 29. Italy Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 30. Russia Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 31. Ireland Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 32. Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 33. Asia-Pacific Peanut Allergy Therapeutics Market Share by Region (2020-2031)

 Figure 34. China Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 35. Japan Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 36. South Korea Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 37. Southeast Asia Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 38. India Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 39. Australia & New Zealand Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 40. Latin America Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 41. Latin America Peanut Allergy Therapeutics Market Share by Country (2020-2031)

 Figure 42. Mexico Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 43. Brazil Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 44. Middle East & Africa Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 45. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2020-2031)

 Figure 46. Israel Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 47. Saudi Arabia Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 48. UAE Peanut Allergy Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 49. Viatris Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 50. Bayer Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 51. UCB Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 52. J & J Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 53. Perrigo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 54. GSK Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 55. Kaleo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 56. Amneal Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 57. ALK Abello Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 58. Aimmune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 59. HUAPONT Pharm Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 60. Allergy Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 61. ASIT Biotech Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 62. Sanofi Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 63. DBV Technologies Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 64. HAL Allergy Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 65. Intrommune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2020-2025)

 Figure 66. Bottom-up and Top-down Approaches for This Report

 Figure 67. Data Triangulation

 Figure 68. Key Executives Interviewed